MedTrace Logo

Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study

NCT02579655 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4764

Last updated 2024-03-22

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of two novel interventions; (1) a value-based formulary which eliminates copayment for selected high-value medications (proven to prevent heart attacks, stroke, and hospitalizations); and (2) a comprehensive patient education program aimed at lifestyle modification and optimal drug use, combined with relay of information on medication use, on the risk of adverse clinical outcomes (mortality, heart attack, stroke, need for coronary revascularization, and chronic disease related hospitalizations) in low-income seniors with chronic conditions over three years of follow-up or until March 31, 2021 (whichever comes first).

Conditions

Interventions

BEHAVIORAL

Copayment Elimination

Patients will receive preventive medications for their chronic conditions free of charge (without the 30% copayment seniors normally pay for their medications)

BEHAVIORAL

Personalized Education

Tailored Education focusing on optimizing use and adherence to guideline recommended medications, as well as appropriate lifestyle

Sponsors & Collaborators

  • Alberta Innovates Health Solutions

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Braden Manns · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2021-03-31
Completion
2021-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579655 on ClinicalTrials.gov